Premenstrual disorders: Premenstrual syndrome and premenstrual dysphoric disorder

Takeda, Takashi

doi:10.1111/jog.15484

Cited by 17 publications

(19 citation statements)

References 96 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The exact pathophysiology of PMDs remains unclear; however, the effectiveness of selective serotonin reuptake inhibitors (SSRIs) as therapeutic agents is reportedly related to the brain transmitter serotonin. 11 Experiments using rat models of social isolation have reported that the serotonin 1A receptor agonist buspirone and the SSRI fluoxetine improve behavioral abnormalities caused by isolation. 38 From this, isolation and loneliness can be inferred to be associated with serotonin.…”

Section: Discussionmentioning

confidence: 99%

“…Premenstrual symptoms are typical of these symptoms; specifically, they consist of a variety of mood, behavioral, and physical symptoms specific to the late luteal period. 10 , 11 Premenstrual disorders (PMDs) consist of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) (a severe form of PMS with predominantly mental symptoms). 12 These are the pathological conditions associated with premenstrual symptoms.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Association Between Loneliness, Premenstrual Symptoms, and Other Factors During the COVID-19 Pandemic: A Cross-Sectional Study with Japanese High School Students

Takeda¹,

Yoshimi²,

Kai³

et al. 2023

IJWH

Self Cite

View full text Add to dashboard Cite

Purpose Adolescence is a period of transition from childhood to adulthood where people are vulnerable to stress. The COVID-19 pandemic continues to cause sustained stress in the population. Since the COVID-19 pandemic, social isolation and loneliness have increased. Loneliness is associated with increased stress, psychological distress, and a higher risk of mental illnesses, such as depression. This study examined the association between loneliness, premenstrual symptoms, and other factors in the era of the COVID-19 pandemic among adolescent females in Japan. Patients and Methods A school-based cross-sectional survey of 1450 adolescent female students in Japan was conducted in mid-December of 2021. Specifically, paper-based questionnaires were distributed in class, and the responses were collected. The Premenstrual Symptoms Questionnaire (PSQ), 6-item Kessler Psychological Distress Scale, 3-item Revised UCLA Loneliness Scale (R-UCLA), and Fear of COVID-19 Scale were used as measurement tools. The prevalence of loneliness was defined as a total R-UCLA score ≥ 6. Results The prevalence of loneliness was 29.0%. The prevalence of serious psychological distress was also high (8.2%), especially in the lonely group (16.0%). Multivariable regression analysis identified the following factors associated with loneliness: second year (odds ratio [OR] 1.53; 95% confidence interval [CI] 1.09–2.14), longer internet use (OR, 1.11; 95% CI, 1.02–1.20), total PSQ score (OR 1.08; 95% CI 1.06–1.11), and psychological distress (OR 1.05; 95% CI 1.01–1.08). Conclusion Adolescent females in Japan showed a high prevalence of loneliness. School year (2nd year), longer periods of internet use, premenstrual symptom severity, and psychological distress were independently associated with loneliness. For clinicians and school health professionals, special concern should be given to the psychological health of adolescent females during the COVID-19 pandemic.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Association Between Loneliness, Premenstrual Symptoms, and Other Factors During the COVID-19 Pandemic: A Cross-Sectional Study with Japanese High School Students

Takeda¹,

Yoshimi²,

Kai³

et al. 2023

IJWH

Self Cite

View full text Add to dashboard Cite

show abstract

“…In the 1950s, the term premenstrual syndrome (PMS) was introduced for physical and psychological symptoms occurring within 2 weeks before menses, with relief occurring after the onset of the menstrual period [ 1 – 3 ]. According to the American Congress of Obstetricians and Gynecologists (ACOG), the diagnostic criteria for PMS include somatic symptoms, such as abdominal bloating, breast tenderness or swelling, headache, joint or muscle pain, swelling of the extremities, and weight gain, as well as mental symptoms, including angry outbursts, anxiety, confusion, depression, irritability, and social withdrawal [ 4 ].…”

Section: Introductionmentioning

confidence: 99%

Effect of γ-tocopherol supplementation on premenstrual symptoms and natriuresis: a randomized, double-blind, placebo-controlled study

Higuchi¹,

Ueno²,

Uchiyama³

et al. 2023

BMC Complement Med Ther

View full text Add to dashboard Cite

Background This randomized, double-blind, placebo-controlled study aimed to investigate the effects of γ-tocopherol (Toc) supplementation on premenstrual symptoms and natriuresis. Methods We enrolled 51 Japanese women with premenstrual symptoms, particularly those who showed increased symptoms induced by water retention during the luteal phase compared with the follicular phase. Premenstrual symptoms were recorded in the first cycle’s postmenstrual follicular phase; physical measurements and urine collection were conducted during the 48-h run-in period. The test supplement, which contained 180 mg of γ-Toc or placebo, was orally administered twice a day for 7 days during the luteal phase of the first and second cycles in a crossover manner. The same evaluation was conducted during the luteal phase, beginning in the morning of the sixth day of supplement administration. Results Compared with placebo intake, γ-Toc intake significantly reduced “fatigue” and “irritability/anger” symptoms. Furthermore, compared with placebo intake, γ-Toc intake significantly reduced the thigh circumference. Regarding the “swelling of the legs” and “heavy legs” symptoms and the thigh circumference, the biphasic trend of increasing and decreasing values in the daytime and morning, respectively, during the follicular phase was not observed at the luteal phase with placebo intake. Contrastingly, γ-Toc intake resulted in significantly lower values in the morning than placebo intake. The mean difference in 24-h urinary sodium excretion between γ-Toc and placebo intake was 10.6 mEq (95% confidence interval (CI): -0.1, 21.4, p = 0.05, power 55%). Plasma γ-Toc and its metabolite γ-carboxyethyl hydroxychroman (CEHC) levels were significantly higher with γ-Toc intake than with placebo intake. There were no significant between-supplement differences in serum electrolyte levels or cumulative urinary potassium excretion. Conclusion γ-Toc intake could effectively alleviate certain premenstrual syndrome symptoms, particularly those related to water retention during the luteal phase. Furthermore, the underlying mechanism may involve the diuretic effect of γ-CEHC, which is a γ-Toc metabolite. Trial registration UMIN000047989; registration date: 10/06/2022, retrospectively registered.

show abstract

“…Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) are characterized by unpleasant mental and physical symptoms that significantly impair the quality of life 1 . In Japan, the social recognition of PMS/PMDD lags behind that of other countries, and treatment for these disorders is not widely available.…”

Section: Introductionmentioning

confidence: 99%

“…In particular, OCs/LEPs containing drospirenone have been verified for their therapeutic effects on PMDD and are considered one of the standard treatments, including PMS 2,4 . In Japan, Kampo, a Japanese herbal medicine, is universally used for treatment 1 . Although obstetricians, gynecologists (OB/GYNs), and psychiatrists are the main providers of PMS/PMDD treatment in Japan, the actual status of the diagnostic and treatment methods used remains unknown.…”

Section: Introductionmentioning

confidence: 99%

Women's Health Care Committee, Japan Society of Obstetrics and Gynecology: Annual report—2023

Terauchi,

Higuchi

2023

J of Obstet and Gynaecol

View full text Add to dashboard Cite

The Women's Health Care Committee was established in 2010 with the goal of improving women's health. In the current academic year, there are six subcommittees focusing on conducting the following surveys: (1) the current status of pregnancy‐associated breast cancer in Japan; (2) surgery for disorders of sex development; (3) diagnosis and treatment of premenstrual syndrome and premenstrual dysphoric disorder; (4) obstetrics and gynecology‐based treatment for patients with eating disorders in Japan; (5) multi‐drug‐resistant bacterial infections in the field of obstetrics and gynecology; and (6) changing the methodology of the treatment of dysmenorrhea and continuing medical education. The activities of each subcommittee are described below. This report is based on the Japanese version of the annual report (Acta Obst Gynaec Jpn 2023;75(6):662–86).

show abstract

Premenstrual disorders: Premenstrual syndrome and premenstrual dysphoric disorder

Cited by 17 publications

References 96 publications

Association Between Loneliness, Premenstrual Symptoms, and Other Factors During the COVID-19 Pandemic: A Cross-Sectional Study with Japanese High School Students

Association Between Loneliness, Premenstrual Symptoms, and Other Factors During the COVID-19 Pandemic: A Cross-Sectional Study with Japanese High School Students

Effect of γ-tocopherol supplementation on premenstrual symptoms and natriuresis: a randomized, double-blind, placebo-controlled study

Women's Health Care Committee, Japan Society of Obstetrics and Gynecology: Annual report—2023

Contact Info

Product

Resources

About